Carol Huang is a reporter at FinanceAsia, where she covers capital market, financial institutions and related technology changes in Greater China. Carol holds a Master of Journalism from the University of Hong Kong. She can be contacted at email@example.com
In partnership with China Investment Corporation (CIC) and BNP Paribas, Eurazeo’s China head tells FinanceAsia how France's largest private equity company plans to spend up to Eur1.5 billion to break into the world’s second largest economy.
After announcing a $100 million Series B+ funding, the biotech company’s CEO tells FinanceAsia it is now in full IPO preparation mode with Hong Kong as its preferred destination. However, a dual listing is not out of the question.
Alibaba’s successful HK listing, combined with mounting pressure from PE investors, is forcing Chinese companies to consider listing in 2020 despite the woeful stock market performance of many who floated in 2019.